Dollars flow with three new public offerings, two private placements
A handful of biotechs announced plans to raise money this week.
First up is Hookipa Pharma, which announced Wednesday night that it is looking to raise $50 million in gross earnings in a public offering — by selling 22.9 million shares of common stock at $1.31 a share. The biotech, which is developing immuno-oncology treatments and infectious disease programs, is also offering roughly 15,000 shares of non-voting preferred stock, which could be converted into 1,000 shares of common stock for a price of $1,310 each.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.